We are all aware that the effects of the organism’s ageing on our health comprise a long list of diseases that all of us fear. Heart disease, cancer, strokes, dementia, are all increasing as age progresses.

Until recently, research focused on the result, i.e. the condition, assuming the main cause, ageing, as something inevitable. 

Revolution had suddenly arrived! Ageing itself was targeted. The concept behind it is simple. Since ageing is the main risk for developing most of the incurable conditions, then the way to improve human health and extend life, not only in terms of time but also in terms of quality, is to delay ageing.

Rapamycin is a drug administered to patients who have undergone transplant, in order for the graft not to be rejected by their organism.

Initial research conducted in experimental animals, showed that their life duration was extended and disease development that is associated with ageing was reduced.

Following these results, the study was applied to 200 volunteers over the age of 65 years who randomly received the experimental drug or a placebo for several weeks. The result was that even small doses of the drug seemed to boost the immune system of the elderly.